blood thinner

Atlanta, February 19: The researchers have developed a new way to give people the proper dose of warfarin, a leading blood thinner, as the wrong amount of the dose can be dangerous.

Warfarin is used worldwide to prevent dangerous blood clots that can lead to heart attacks, strokes or even death. Every year, about 4 million Americans with certain heart conditions or other risk factors take warfarin.

Washington, January 31: U.S. health regulatory officials declared Friday that the blood thinner, prasugrel jointly made by Eli Lilly and Co. and Daiichi Sankyo Co., Ltd. is more effec

“Superiority, not to a placebo, but to an active drug ..., prasugrel's efficacy seems beyond question," said United States Food and Drug Administration (FDA) staff reviewers, indicating approval.

Washington, United States, January 8: One of the first of its kind, anti-clotting drug, named ATryn, developed from genetically engineered goats is on its way to approval by the government.

The latest medication has been made in order to make life easier for people, who suffer from a rare hereditary disease that makes them susceptible to blood clots.

GTC Biotherapeutics, a Massachusetts biotechnology company, has developed ATryn. The drug is manufactured by manipulating the genesdefine of goats. This is done in such a way that the goats produce milk, which is high in antithrombin, a protein that makes human blood thinner naturally.